PL4045022T3 - Kompozycja do zapobiegania taopatiom i ich leczenia - Google Patents

Kompozycja do zapobiegania taopatiom i ich leczenia

Info

Publication number
PL4045022T3
PL4045022T3 PL20780933.6T PL20780933T PL4045022T3 PL 4045022 T3 PL4045022 T3 PL 4045022T3 PL 20780933 T PL20780933 T PL 20780933T PL 4045022 T3 PL4045022 T3 PL 4045022T3
Authority
PL
Poland
Prior art keywords
preventing
composition
treating tauopathies
tauopathies
treating
Prior art date
Application number
PL20780933.6T
Other languages
English (en)
Inventor
Fernando Rodriguez De Fonseca
Juan Antonio NAVARRO GALERA
Elena Baixeras Llano
Juan Manuel Decara Del Olmo
Dina MEDINA VERA
Antonio Jesús LÓPEZ GAMBERO
Juan SUAREZ PEREZ
Carlos Sanjuan Merino
Cristina Rosell Del Valle
Francisco Javier PAVÓN MORÓN
Original Assignee
Servicio Andaluz De Salud
Euronutra, S.L.
Universidad De Málaga
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servicio Andaluz De Salud, Euronutra, S.L., Universidad De Málaga filed Critical Servicio Andaluz De Salud
Publication of PL4045022T3 publication Critical patent/PL4045022T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL20780933.6T 2019-09-09 2020-09-09 Kompozycja do zapobiegania taopatiom i ich leczenia PL4045022T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382778.9A EP3789018A1 (en) 2019-09-09 2019-09-09 Composition and methods for enhancing or promoting the secretion of ghrelin to promote a healthy metabolic aging
PCT/EP2020/075180 WO2021048195A2 (en) 2019-09-09 2020-09-09 Composition and methods for enhancing or promoting a healthy metabolic aging

Publications (1)

Publication Number Publication Date
PL4045022T3 true PL4045022T3 (pl) 2025-11-17

Family

ID=67902476

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20780933.6T PL4045022T3 (pl) 2019-09-09 2020-09-09 Kompozycja do zapobiegania taopatiom i ich leczenia

Country Status (8)

Country Link
US (1) US20220313620A1 (pl)
EP (3) EP3789018A1 (pl)
JP (2) JP2022547641A (pl)
CN (2) CN120938973A (pl)
CA (1) CA3153663A1 (pl)
ES (1) ES3041902T3 (pl)
PL (1) PL4045022T3 (pl)
WO (1) WO2021048195A2 (pl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US20060004096A1 (en) * 2004-05-28 2006-01-05 Joseph Larner Method of Treating Endothelial Dysfunction, Oxidative Stress and Related Diseases
JP2008510494A (ja) * 2004-08-25 2008-04-10 マルチ・フォーミュレーションズ・リミテッド 骨格筋における異化過程の失活及びタンパク質合成のための組成物並びに方法
US8193250B2 (en) * 2004-10-22 2012-06-05 Mount Sinai School Of Medicine Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system
WO2008025116A1 (en) * 2006-08-31 2008-03-06 New Nitro Formulations Ltd. Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle
KR100844363B1 (ko) * 2007-09-05 2008-07-07 충남대학교산학협력단 D-피니톨을 유효성분으로 포함하는 골 대사성 질환의 예방 또는 치료용 조성물
CN101612142A (zh) * 2008-06-25 2009-12-30 广州威尔曼新药开发中心有限公司 肌醇衍生物或其盐在制药中的用途
ITFI20110252A1 (it) * 2011-11-22 2013-05-23 Lo Li Pharma Srl Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
CA2941650A1 (en) * 2014-03-05 2015-09-11 Humanetics Corporation Predicting and reducing cognitive decline based on gsk-3 levels
KR101671502B1 (ko) * 2015-07-13 2016-11-02 주식회사 디와이내츄럴 피니톨, d-카이로-이노시톨, 또는 이들의 유사 화합물을 유효성분으로 포함하는 여성 갱년기 증상의 개선, 예방, 또는 치료용 조성물
JP6838146B2 (ja) * 2016-10-06 2021-03-03 ディーワイ ナチュラル カンパニー リミテッド ピニトール、d−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物

Also Published As

Publication number Publication date
WO2021048195A9 (en) 2022-04-21
JP2025169353A (ja) 2025-11-12
CN120938973A (zh) 2025-11-14
JP2022547641A (ja) 2022-11-14
EP4045022A2 (en) 2022-08-24
CN114641281A (zh) 2022-06-17
CA3153663A1 (en) 2021-03-18
EP4045022B1 (en) 2025-07-09
EP4045022C0 (en) 2025-07-09
US20220313620A1 (en) 2022-10-06
EP4599696A2 (en) 2025-08-13
WO2021048195A3 (en) 2021-04-29
EP3789018A1 (en) 2021-03-10
ES3041902T3 (en) 2025-11-17
EP4599696A3 (en) 2026-01-07
WO2021048195A2 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
SG11202104158SA (en) Composition and method for treating the lungs
SG11202103405TA (en) Compounds and compositions for treating conditions associated with nlrp activity
SG11202013239RA (en) Composition and method for treating pain
IL286350A (en) Preparations and methods for the treatment of cancer
IL288914A (en) Preparations and methods for the treatment of cancer
IL285886A (en) Preparations and methods for the treatment of laminopathy
ZA202104870B (en) Methods and compositions for treating cancer
IL271256A (en) Preparations and methods for the treatment of teopathy
IL288024A (en) Methods and preparations for the prevention of type 1 diabetes
IL285796A (en) Methods and preparations for the treatment of cancer
HUE073261T2 (hu) Készítmények fehérje-aggregációs betegségek kezelésére és/vagy megelõzésére
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
IL280413A (en) Bismuth-thiol preparations and wound treatment methods
IL287982A (en) Preparations and methods for the treatment of cancer
IL286153A (en) Methods and preparations for the treatment of cancer
ZA202007183B (en) Compositions and methods for treating the eye
IL288440A (en) Materials and methods for the treatment of retinopathy
GB202001422D0 (en) Compositions and methods for preventing or treating nephrolithiasis
SG11202107355RA (en) Improved method and compositions for surface treatment
GB202110228D0 (en) Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
GB2596927B (en) Composition for preventing or treating dementia and improving cognitive ability
GB2579687B (en) Composition and method
PL4045022T3 (pl) Kompozycja do zapobiegania taopatiom i ich leczenia
IL285036A (en) Methods and preparations for the treatment of cancer
SG11202112052VA (en) Compositions and methods for treating presbyopia